Phase I/II Trial of a Combination of Anti-CD3/CD7 Immunotoxins for Steroid-Refractory Acute Graft-versus-Host Disease.

MLA

Groth, Christoph, et al. “Phase I/II Trial of a Combination of Anti-CD3/CD7 Immunotoxins for Steroid-Refractory Acute Graft-versus-Host Disease.” Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation, vol. 25, no. 4, Apr. 2019, pp. 712–19. EBSCOhost, https://doi.org/10.1016/j.bbmt.2018.10.020.

APA

Groth, C., van Groningen, L. F. J., Matos, T. R., Bremmers, M. E., Preijers, F. W. M. B., Dolstra, H., Reicherts, C., Schaap, N. P. M., van Hooren, E. H. G., IntHout, J., Masereeuw, R., Netea, M. G., Levine, J. E., Morales, G., Ferrara, J. L., Blijlevens, N. M. A., van Oosterhout, Y. V. J. M., Stelljes, M., & van der Velden, W. J. F. M. (2019). Phase I/II Trial of a Combination of Anti-CD3/CD7 Immunotoxins for Steroid-Refractory Acute Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation, 25(4), 712–719. https://doi.org/10.1016/j.bbmt.2018.10.020

Chicago

Groth, Christoph, Lenneke F J van Groningen, Tiago R Matos, Manita E Bremmers, Frank W M B Preijers, Harry Dolstra, Christian Reicherts, et al. 2019. “Phase I/II Trial of a Combination of Anti-CD3/CD7 Immunotoxins for Steroid-Refractory Acute Graft-versus-Host Disease.” Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation 25 (4): 712–19. doi:10.1016/j.bbmt.2018.10.020.